Trial Profile
Clinical Trials Insight: 700028390
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2010
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi Pasteur
- 08 Jul 2010 Crucell assumes full development rights for Sanofi Pasteur's cell-based influenza vaccine programme. Application for approval is estimated for 2014.
- 13 Nov 2007 New trial record.